Compare Hims and Hers Health Inc (HIMS) vs Rivian Automotive, Inc. (RIVN) Price & Performance

HIMS stock declined 7.11% to $29.51 following mixed Q2 2026 results, where revenue beat expectations but the company posted a wider-than-expected loss. The technical picture is neutral with bearish moving average signals, while fundamentals show strong revenue growth but deteriorating margins. Recent news highlights margin pressure from GLP-1 drug investments and an FTC investigation, creating investor uncertainty despite raised revenue guidance.

The outlook remains cautious as strong subscriber growth and AI initiatives are offset by profitability challenges and regulatory scrutiny. Investment opportunity exists in the company's expanding global footprint and raised revenue targets, but risks include margin compression, negative cash flow trends, and ongoing legal investigations that could pressure the stock near-term.

Rivian (RIVN) trades at $16.005, down 2.35% on the day, with a bullish technical signal from moving averages but mixed oscillators. The company continues to report significant losses, with a net income margin of -54.95% for 2025, though revenue has grown to $5.39 billion. Recent news highlights the R2 vehicle launch and a partnership with Uber, providing potential growth catalysts amid ongoing cash burn concerns.

The outlook remains speculative; RIVN offers high growth potential through new vehicle ramps and software margins, but substantial execution risks and negative cash flow pose threats to near-term stability. Analyst consensus is cautiously optimistic with a $18.70 price target, yet the stock's path depends heavily on achieving profitability milestones.